Market Access News | pharmaphorum

News

Gilead Sciences has taken a major step towards increasing global access to HIV prevention with the signing of royalty-free

News

In the VP debate, Tim Walz and JD Vance were forceful, unexpectedly convivial, and fast and loose with the facts, particularly on healthcare.

News

Blue Shield of California is pioneering a strategy that bypasses traditional pharmacy benefit managers to slash the price of Humira by up to 90%

News

The US Food and Drug Administration (FDA) has provided an ‘at-a-glance’ summary of the agency’s news.

News

Johnson & Johnson's stand against 340B abuse and duplicate discounts came to a halt in the face of HRSA threats of termination.

News

Originally anticipated in June, the FDA action stands to make Sanofi and Regeneron's biologic blockbuster even bigger.